Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT05402384
What this trial is testing

AVTX-801 D-galactose Supplementation in SLC35A2-CDG

Who this might be right for
SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation
Eva Morava-Kozicz 10
Not applicableUnknownNCT04833322
What this trial is testing

Galactose Supplementation for the Treatment of MOGHE

Who this might be right for
Refractory EpilepsySLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation
Hospital Ruber Internacional 8

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation